Literature DB >> 27378054

A study on the predictors of Korean male students' intention to receive human papillomavirus vaccination.

Jeong Sil Choi1, Seungmi Park2.   

Abstract

AIMS AND
OBJECTIVES: The objective was to survey the current state of human papillomavirus (HPV) vaccination and the predictors of vaccination intention among Korean male students of high school (ages 15-19) and university (ages 17-27).
BACKGROUND: Human papillomavirus is a sexually transmitted infectious agent causing uterine cervical, anal, and/or penile cancer and genital warts in males and females. Infection rate of human papillomavirus increases from the age when sexual intercourse first occurs. Therefore, motivation to receive human papillomavirus vaccination is needed to protect infection.
DESIGN: Cross-sectional descriptive survey was performed only in male students. They are less aware of human papillomavirus than females, because human papillomavirus vaccination has been targeted on females for preventing cervical cancer in Korea.
METHODS: Data were collected using a self-reporting questionnaire for male high school and university students sampled from a city in Korea. Human papillomavirus vaccine-related knowledge, health beliefs, demographic, and sexual history information variables relating to intentions to vaccinate were assessed.
RESULTS: The human papillomavirus vaccination rate was very low and the levels of knowledge and health beliefs were low. The significant predictors that raised the intention of human papillomavirus vaccination were a university student, experience of sexual intercourse and perceiving the benefits of human papillomavirus vaccination.
CONCLUSIONS: To promote human papillomavirus vaccination, educational programming targeting males should include health beliefs and knowledge, emphasising that vaccination is important to prevent uterine cervical cancer and to role as a preventative measure against common male diseases. RELEVANCE TO CLINICAL PRACTICE: Male high school students should be included as a major target population for school human papillomavirus education programmes, as they are at the age of commencing sexual intercourse. In addition, public health policies including human papillomavirus vaccination in the national immunisation programme are warranted.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  Korea; human papillomavirus vaccination; male; risk factor

Mesh:

Substances:

Year:  2016        PMID: 27378054     DOI: 10.1111/jocn.13461

Source DB:  PubMed          Journal:  J Clin Nurs        ISSN: 0962-1067            Impact factor:   3.036


  5 in total

1.  Vaccine attitudes among young adults in Asia: a systematic review.

Authors:  Li Wang; Yuanyuan Liang; Xuan Zhang; Jinxia Yang
Journal:  Hum Vaccin Immunother       Date:  2020-10-15       Impact factor: 3.452

2.  Willingness of parents to vaccinate their 6-60-month-old children with EV71 vaccines: a cross-sectional study in rural areas of northern Jiangsu Province.

Authors:  Yuanyuan Wang; Fanyu Meng; Jingxin Li; Guifan Li; Jialei Hu; Jiaqian Cao; Qiufan Yu; Qi Liang; Fengcai Zhu
Journal:  Hum Vaccin Immunother       Date:  2020-03-25       Impact factor: 3.452

3.  Do Male University Students Know Enough About Human Papillomavirus (HPV) to Make Informed Decisions About Vaccination?

Authors:  Shuai Wang; Bingfeng Han; Yongmei Wan; Jiang Liu; Tianshuo Zhao; Hanyu Liu; Fuqiang Cui
Journal:  Med Sci Monit       Date:  2020-06-30

Review 4.  Factors Associated with the HPV Vaccination among Korean Americans and Koreans: A Systematic Review.

Authors:  Soojung Jo; Soo-Yeon Han; Connor A Walters
Journal:  Int J Environ Res Public Health       Date:  2021-12-21       Impact factor: 3.390

5.  Investigating host-virus interaction mechanism and phylogenetic analysis of viral proteins involved in the pathogenesis.

Authors:  Ahmad Abu Turab Naqvi; Farah Anjum; Alaa Shafie; Sufian Badar; Abdelbaset Mohamed Elasbali; Dharmendra Kumar Yadav; Md Imtaiyaz Hassan
Journal:  PLoS One       Date:  2021-12-16       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.